Exchange: NASDAQ·Updated 08:40 AM EDT
XAIR logo

XAIR Beyond Air Inc

$3.78
$0.19
(4.79%)
Pre-Market
Prev Close $3.97
Reported EarningsAug 13
Mkt Cap$3.91M
Vol63,355.00

About XAIR

Beyond Air, Inc. is a commercial stage medical device and biopharmaceutical company, which engages in the development of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from respiratory illnesses, neurological disorders, and solid tumors. It operates through the Beyond Air, Beyond Cancer segments, and NeuroNos. The company was founded on April 28, 2015 and is headquartered in Garden City, NY.
77

Extremely Bullish Sentiment

How do you feel about XAIR?

Advertisement|Remove ads.